Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at carboplatin, gemcitabine and vandetanib for advanced transitional cell cancer that has spread (TOUCAN)

Overview

Cancer types:

Bladder cancer, Kidney cancer, Transitional cell cancer

Status:

Results

Phase:

Phase 2

Details

This trial was for people with transitional cell cancer that had grown into surrounding tissue (locally advanced) or spread elsewhere in the body.

Cancer Research UK supported this trial.

Recruitment start: 1 July 2010

Recruitment end: 16 December 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rob Jones

Supported by

AstraZeneca

Cancer Research UK

Cardiff University

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Wales Cancer Trials Unit (WCTU)

National Cancer Research Institute (NCRI)

Other information

This is Cancer Research UK trial number CRUKE/09/024.

Last reviewed: 8 September 2016

CRUK internal database number: 4129

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.